Literature DB >> 12677433

Pathophysiology of generalized pustular psoriasis.

Hajime Iizuka1, Hidetoshi Takahashi, Akemi Ishida-Yamamoto.   

Abstract

Generalized pustular psoriasis (GPP) is a serious dermatological disease characterized by fever, chills, rigors, and generalized pustule formation on the skin. Previous analyses in Japan have led to the proposal to divide GPP into two groups, one with a history of ordinary psoriasis (pso(+) GPP) and the other without a history of psoriasis (pso(-) GPP). Clinically the onset of the pustular outbreak is earlier in pso(-) GPP, which occurs more frequently after infections, whereas pso(+) GPP occurs more frequently following corticosteroid therapy. Substantial differences are also noted in HLA analyses. Activation of neutrophils is a basic mechanism in both types of GPP. Although the epidermal structural changes in GPP are usually not so prominent as those in psoriasis vulgaris, pso(+) GPP shows a more psoriasiform architecture than pso(-) GPP. Analysis of epidermal cell proliferation in GPP indicates that it is not less than that seen in psoriasis vulgaris. The occasional psoriasiform epidermal architecture especially seen in pso(+) GPP may be considered to be a steady-state condition achieved after epidermal cell proliferation has continued for a sustained period. Various inflammatory cytokines appear to be involved in the neutrophilic infiltrate seen in GPP.

Entities:  

Mesh:

Year:  2003        PMID: 12677433     DOI: 10.1007/s00403-002-0372-5

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  5 in total

1.  Serum procalcitonin and C-reactive protein in the evaluation of bacterial infection in generalized pustular psoriasis.

Authors:  Siyu Wang; Zhen Xie; Zhu Shen
Journal:  An Bras Dermatol       Date:  2019-09-30       Impact factor: 1.896

2.  Generalized pustular psoriasis induced by systemic steroid dose reduction.

Authors:  Danielle Cristine Westphal; Antonio Pedro Mendes Schettini; Petra Pereira de Souza; Jessica Castiel; Carlos Alberto Chirano; Mônica Santos
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

Review 3.  Pustular psoriasis: pathophysiology and current treatment perspectives.

Authors:  Katie E Benjegerdes; Kimberly Hyde; Dario Kivelevitch; Bobbak Mansouri
Journal:  Psoriasis (Auckl)       Date:  2016-09-12

4.  Juvenile interleukin-36 receptor antagonist deficiency (DITRA) with c.80T>C (p.Leu27Pro) mutation successfully treated with etanercept and acitretin.

Authors:  Edwin Cuperus; Rosanne Koevoets; Jasper J van der Smagt; Johan Toonstra; Marlies de Graaf; Joost Frenkel; Suzanne G M A Pasmans
Journal:  JAAD Case Rep       Date:  2018-02-02

Review 5.  Pustular Psoriasis: From Pathophysiology to Treatment.

Authors:  Giovanni Genovese; Chiara Moltrasio; Nicoletta Cassano; Carlo Alberto Maronese; Gino Antonio Vena; Angelo Valerio Marzano
Journal:  Biomedicines       Date:  2021-11-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.